Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2017 | 10-2016 | 07-2016 | 04-2016 | 01-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,289 | -2,007 | -1,032 | -6,064 | -4,942 |
| Accounts payable and accrued liabilities | 99 | -35 | -24 | -161 | 201 |
| Other Working Capital | 30 | -129 | -126 | -874 | -344 |
| Other Operating Activity | 622 | 558 | 275 | 2,752 | 1,958 |
| Operating Cash Flow | $-2,539 | $-1,613 | $-907 | $-4,346 | $-3,128 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,081 | 1,243 | 1,326 | 3,568 | 3,292 |
| Financing Cash Flow | $3,081 | $1,243 | $1,326 | $3,568 | $3,292 |
| Exchange Rate Effect | 1 | 1 | 0 | -1 | 0 |
| Beginning Cash Position | 1,921 | 1,921 | 1,921 | 2,700 | 2,700 |
| End Cash Position | 2,464 | 1,552 | 2,340 | 1,921 | 2,864 |
| Net Cash Flow | $543 | $-369 | $419 | $-779 | $164 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,539 | -1,613 | -907 | -4,346 | -3,128 |
| Free Cash Flow | -2,539 | -1,613 | -907 | -4,346 | -3,128 |